LimmaTech Biologics

Recent Finacing

Series A

Recent Raise

$36.3M

LimmaTech Biologics is a Swiss company that develops vaccines against multidrug-resistant bacterial infections, with a focus on shigellosis and gonorrhea, using E. coli expression systems.